title: Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux.
authors.affiliation: Center for Vascular Medicine and Department of Medicine III, Technical University Dresden, Fetscherstrasse 74, 01307 Dresden, Germany. Jan.Beyer@uniklinikum-dresden.de
authors.forename: Jan
authors.initials: J
authors.lastname: Beyer-Westendorf
authors.forename: Sebastian
authors.initials: S
authors.lastname: Werth
authors.forename: Gunnar
authors.initials: G
authors.lastname: Folprecht
authors.forename: Norbert
authors.initials: N
authors.lastname: Weiss
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000188:drug therapy*; D000925:Anticoagulants / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D000077425:Fondaparinux; D006801:Humans; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000150:complications / Q000188:drug therapy*; D011134:Polysaccharides / Q000627:therapeutic use*; D013577:Syndrome; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000150:complications / Q000188:drug therapy*; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D011134:Polysaccharides; D015091:beta-Alanine; D000069604:Dabigatran; D000077425:Fondaparinux